within Pharmacolibrary.Drugs.ATC.N;

model N01AX07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 15.6 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 20 / 1000000,
    adminCount     = 1,
    Vd             = 0.0022,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Etomidate is a short-acting intravenous anesthetic agent used for the induction of general anesthesia and sedation for short procedures. It is known for its rapid onset and minimal cardiovascular effects, making it particularly useful in patients with hemodynamic instability. It is approved and clinically used for anesthesia induction.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects after intravenous bolus administration.</p><h4>References</h4><ol><li><p>Lauven, PM, &amp; Schüttler, J (1993). [Pharmacodynamics and pharmacokinetics of the newer intravenous anesthetics (etomidate, propofol, S-ketamine)]. <i>Klinische Anasthesiologie und Intensivtherapie</i> 44 3–113. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8510438/&quot;>https://pubmed.ncbi.nlm.nih.gov/8510438</a></p></li><li><p>Dumps, C, et al., &amp; Halbeck, E (2017). [Etomidate for intravenous induction of anaesthesia]. <i>Der Anaesthesist</i> 66(12) 969–980. DOI:<a href=&quot;https://doi.org/10.1007/s00101-017-0381-6&quot;>10.1007/s00101-017-0381-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29147790/&quot;>https://pubmed.ncbi.nlm.nih.gov/29147790</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N01AX07;
